119 related articles for article (PubMed ID: 21144970)
1. Biomarker-guided treatment of heart failure: still waiting for a definitive answer.
Troughton RW; Frampton CM; Nicholls MG
J Am Coll Cardiol; 2010 Dec; 56(25):2101-4. PubMed ID: 21144970
[No Abstract] [Full Text] [Related]
2. Q: Should target natriuretic peptide levels be used for outpatient management of chronic heart failure?
Ibrahim A; Baibars M; Alraies MC; Oliveira GH
Cleve Clin J Med; 2012 Jan; 79(1):22-5. PubMed ID: 22219230
[No Abstract] [Full Text] [Related]
3. Biomarker-guided therapy in chronic heart failure: a meta-analysis of randomized controlled trials.
Felker GM; Hasselblad V; Hernandez AF; O'Connor CM
Am Heart J; 2009 Sep; 158(3):422-30. PubMed ID: 19699866
[TBL] [Abstract][Full Text] [Related]
4. Natriuretic peptide-guided therapy for heart failure: ready for "battle" or too "scarred" by the challenges of trial design?
Maisel A
J Am Coll Cardiol; 2009 Dec; 55(1):61-4. PubMed ID: 20117365
[No Abstract] [Full Text] [Related]
5. NTproBNP-guided drug treatment for chronic heart failure: design and methods in the "BATTLESCARRED" trial.
Lainchbury JG; Troughton RW; Frampton CM; Yandle TG; Hamid A; Nicholls MG; Richards AM
Eur J Heart Fail; 2006 Aug; 8(5):532-8. PubMed ID: 16829189
[TBL] [Abstract][Full Text] [Related]
6. Can natriuretic peptides help identify heart failure patients for whom statins are beneficial?
Daniels LB; Barrett-Connor E
J Am Coll Cardiol; 2009 Nov; 54(20):1860-1. PubMed ID: 19892236
[No Abstract] [Full Text] [Related]
7. N-terminal pro-B-type natriuretic peptide-guided treatment for chronic heart failure: results from the BATTLESCARRED (NT-proBNP-Assisted Treatment To Lessen Serial Cardiac Readmissions and Death) trial.
Lainchbury JG; Troughton RW; Strangman KM; Frampton CM; Pilbrow A; Yandle TG; Hamid AK; Nicholls MG; Richards AM
J Am Coll Cardiol; 2009 Dec; 55(1):53-60. PubMed ID: 20117364
[TBL] [Abstract][Full Text] [Related]
8. Interpretation of amino-terminal pro-brain natriuretic peptide levels in the HPS and the CORONA study.
Cleland JG; Squire I; Ng L
J Am Coll Cardiol; 2008 Sep; 52(13):1104-5. PubMed ID: 18848145
[No Abstract] [Full Text] [Related]
9. B-type natriuretic peptide in heart failure.
Moe GW
Curr Opin Cardiol; 2006 May; 21(3):208-14. PubMed ID: 16601459
[TBL] [Abstract][Full Text] [Related]
10. Brain natriuretic peptide is unchanged after 4 weeks of continuous positive airway pressure therapy.
Pepperell J; Stradling J; Davies R
J Sleep Res; 2006 Dec; 15(4):463-4. PubMed ID: 17118104
[No Abstract] [Full Text] [Related]
11. Natriuretic peptides in patients with atrial fibrillation and advanced chronic heart failure: determinants and prognostic value of (NT-)ANP and (NT-pro) BNP.
Shelton RJ; Goode K; Cleland JG
Europace; 2007 Feb; 9(2):147; author reply 148. PubMed ID: 17227813
[No Abstract] [Full Text] [Related]
12. [Drug therapy of heart insufficiency guided by hormone measurements].
Kjaer A; Haunsø S
Ugeskr Laeger; 2001 Jan; 163(3):304. PubMed ID: 11219112
[No Abstract] [Full Text] [Related]
13. Natriuretic peptide-guided management of acutely destabilized heart failure: rationale and treatment algorithm.
Bhardwaj A; Januzzi JL
Crit Pathw Cardiol; 2009 Dec; 8(4):146-50. PubMed ID: 19952548
[TBL] [Abstract][Full Text] [Related]
14. [TOPCAT study. Heart failure: spironolactone disappoints in the "problem patient"].
Overbeck P
MMW Fortschr Med; 2013 Dec; 155(21-22):26. PubMed ID: 24724258
[No Abstract] [Full Text] [Related]
15. Rosuvastatin and cardiovascular continuum when time is important.
Barrios V; Escobar C
J Am Coll Cardiol; 2010 Apr; 55(15):1645-6; author reply 1646. PubMed ID: 20378088
[No Abstract] [Full Text] [Related]
16. Plasma NT-proBNP: a new biomarker for diagnosis and monitoring of congestive heart failure (CHF).
Bayes-Genis A
Timely Top Med Cardiovasc Dis; 2006 Apr; 10():E10. PubMed ID: 17066132
[No Abstract] [Full Text] [Related]
17. Natriuretic peptide testing for heart failure therapy guidance in the inpatient and outpatient setting.
Green SM; Green JA; Januzzi JL
Am J Ther; 2009; 16(2):171-7. PubMed ID: 19300043
[TBL] [Abstract][Full Text] [Related]
18. Can B-type natriuretic peptides replace heart failure risk models?
Levy WC
Eur J Heart Fail; 2008 Mar; 10(3):224-5. PubMed ID: 18313983
[No Abstract] [Full Text] [Related]
19. [Biomarkers in heart failure: BNP and NT-proBNP].
Ho CC; Liu CC
Hu Li Za Zhi; 2009 Oct; 56(5):16-22. PubMed ID: 19760573
[TBL] [Abstract][Full Text] [Related]
20. Amino-terminal pro-brain natriuretic peptide: a biomarker for diagnosis, prognosis and management of heart failure.
Morello AM; Januzzi JL
Expert Rev Mol Diagn; 2006 Sep; 6(5):649-62. PubMed ID: 17009901
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
